Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

LXEOLXEO
9 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in LEXEO THERAPEUTICS INC

RA CAPITAL MANAGEMENT, L.P. holds 5M shares of LXEO (LEXEO THERAPEUTICS INC), worth $23.3M as of 2026-Q2. LXEO represents 0.2% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$23.3M

Current Shares

5M

Total Value Change

+$12.9M

Total Shares Change

+4.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
5M
0.0%
$23.3M0.2%$4.66
0
2026-Q1
Unchanged
5M
0.0%
$28.7M0.3%$7.07
0
2025-Q4
New
5M
-
$49.7M0.5%$9.74
57
2025-Q2
Exited
0
-100.0%
$00.0%$4.12
0
2025-Q1
Unchanged
546,554
0.0%
$1.9M0.0%$4.10
0
2024-Q4
Unchanged
546,554
0.0%
$3.6M0.0%$6.54
0
2024-Q3
Decreased
546,554
-18.8%
$4.9M0.1%$9.11
0
2024-Q2
Increased
672,712
+1.8%
$10.8M0.1%$16.04
34
2024-Q1
New
660,938
-
$10.4M0.1%$15.68
46

Other major holders of LXEO: Janus Henderson Group Ltd., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used